Clinical Trial Update: Intranasal Inhalations of Bioactive Factors Produced by M2 Macrophages in Patients With Organic Brain Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intranasal inhalations of bioactive factors produced by M2 macrophages in patients with organic brain syndrome and related…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurocognitive Disorders
• Organic Brain Syndrome

Snippet

Sponsor: Russian Academy of Medical Sciences | Conditions: Organic Brain Syndrome, Nonpsychotic, Neurocognitive Disorders | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-18